Administer your usual dose on your next scheduled day
The misuse of GLP-1 drugs without clinical oversight can lead to severe health complications. GLP-1 receptor agonist drugs carry serious side effects ranging from nausea and vomiting to pancreatitis, acute kidney injury, bowel obstruction, and medullary thyroid cancer, the Ministry of Health and Family Welfare warned on 1 April, 2026
We recommend that you consult with a qualified healthcare provider prior to making any medical decisions or changing any medications or dosages
Dual and Triple Agonists: The next generation of medications, such as Tirzepatide (which targets both GLP-1 and GIP receptors), are already demonstrating even greater efficacy for weight loss and blood sugar control
GLP-1 telehealth prescribing refers to the use of virtual healthcare platforms to evaluate patients and prescribe GLP-1 receptor agonists remotely
Tracking is available via email and the patient portal